EGFR and telangiectasis: The resulting inflammatory cell recruitment and subsequent cutaneous injury account for the majority of dermatological symptoms associated with anti-EGFR therapy including papulopustular eruption, hair growth disorders, periungual and nail plate abnormalities, xerosis, telangiectasias, and pruritus13,21–29.